Bellevue Group AG - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$5,574,001
-74.0%
1,290,278
-54.7%
0.07%
-75.9%
Q3 2022$21,405,000
-20.3%
2,846,457
+6.6%
0.31%
-19.2%
Q2 2022$26,848,000
-9.9%
2,671,413
+11.0%
0.38%
+9.8%
Q1 2022$29,784,0002,405,8250.35%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders